Alex Vasilev
Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
Vasilev, Alex; Sofi, Roba; Smith, Stuart J.; Rahman, Ruman; Teschemacher, Anja G.; Kasparov, Sergey
Authors
Roba Sofi
Dr STUART SMITH stuart.smith@nottingham.ac.uk
CLINICAL ASSOCIATE PROFESSOR
Professor Ruman Rahman RUMAN.RAHMAN@NOTTINGHAM.AC.UK
PROFESSOR OF MOLECULAR NEURO-ONCOLOGY
Anja G. Teschemacher
Sergey Kasparov
Abstract
One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase patient survival, it is necessary to cleanse the adjacent tissue from GBM infiltrates. This requires an innovative local approach. One such approach is that of photodynamic therapy (PDT) which uses specific light-sensitizing agents called photosensitizers. Here, we show that tetramethylrhodamine methyl ester (TMRM), which has been used to asses mitochondrial potential, can be used as a photosensitizer to target GBM cells. Primary patient-derived GBM cell lines were used, including those specifically isolated from the infiltrative edge. PDT with TMRM using low-intensity green light induced mitochondrial damage, an irreversible drop in mitochondrial membrane potential and led to GBM cell death. Moreover, delayed photoactivation after TMRM loading selectively killed GBM cells but not cultured rat astrocytes. The efficacy of TMRM-PDT in certain GBM cell lines may be potentiated by adenylate cyclase activator NKH477. Together, these findings identify TMRM as a prototypical mitochondrially targeted photosensitizer with beneficial features which may be suitable for preclinical and clinical translation.
Citation
Vasilev, A., Sofi, R., Smith, S. J., Rahman, R., Teschemacher, A. G., & Kasparov, S. (2021). Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM). Biomedicines, 9(10), Article 1453. https://doi.org/10.3390/biomedicines9101453
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 9, 2021 |
Online Publication Date | Oct 13, 2021 |
Publication Date | Oct 13, 2021 |
Deposit Date | Mar 4, 2022 |
Publicly Available Date | Mar 8, 2022 |
Journal | Biomedicines |
Electronic ISSN | 2227-9059 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 10 |
Article Number | 1453 |
DOI | https://doi.org/10.3390/biomedicines9101453 |
Keywords | General Biochemistry, Genetics and Molecular Biology; Medicine (miscellaneous) |
Public URL | https://nottingham-repository.worktribe.com/output/7351302 |
Publisher URL | https://www.mdpi.com/2227-9059/9/10/1453 |
Files
Feasibility of Photodynamic Therapy for Glioblastoma
(5.4 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search